A 12-month pilot study of Pacira BioScience’s iovera for chronic lower back pain showed it was favorable compared to compared to radiofrequency ablation, according to a Dec. 2 news release.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback